Takaori Kyoichi
Department of General and Gastroenterological Surgery, Osaka Medical College, 2-7 Daigakumachi, Takatsuki, Osaka 569-8686, Japan.
J Hepatobiliary Pancreat Surg. 2007;14(3):217-23. doi: 10.1007/s00534-006-1165-6. Epub 2007 May 29.
Precursors to pancreatic cancer have been investigated for a century. Previous studies have revealed three distinct precursors, i.e. mucinous cystic neoplasm (MCN), intraductal papillary mucinous neoplasm (IPMN), and pancreatic intraepithelial neoplasia (PanIN), harboring identical or similar genetic alterations as does invasive pancreatic carcinoma. The current understanding of precursors to pancreatic cancer can be illustrated by progressive pathways from noninvasive MCN, IPMN, and PanIN toward invasive carcinoma. MCNs consist of ovarian-type stroma and epithelial lining with varying grades of atypia, and are occasionally associated with invasive adenocarcinoma. The epithelium of noninvasive IPMNs shows a variety of different directions of differentiation, including gastric, intestinal, pancreatobiliary (PB), and oncocytic types. IPMNs can also harbor varying grades of architectural and cytologic atypia. IPMNs confined to branch ducts are mostly the gastric type, and IPMNs involving the main ducts are often intestinal type, while PB and oncocytic types are rare. Small (<1 cm) IPMNs of the gastric type are not always morphologically distinguishable from low-grade PanINs. Mucin expression profiles suggest intestinal-type IPMNs progress to mucinous noncystic (colloid) carcinoma, while PB-type IPMNs progress toward ductal adenocarcinoma. It is a well-described paradigm that PanIN lesions progress toward ductal adenocarcinoma through step-wise genetic alterations. The activation of Hedgehog and Notch signaling pathways in PanIN lesions as well as in pancreatic adenocarcinoma suggest that developmental pathways may be disregulated during carcinogenesis of the pancreas. Further study is needed to elucidate the pathways from precursors toward invasive carcinoma of the pancreas.
胰腺癌的癌前病变已被研究了一个世纪。以往的研究已经揭示了三种不同的癌前病变,即黏液性囊性肿瘤(MCN)、导管内乳头状黏液性肿瘤(IPMN)和胰腺上皮内瘤变(PanIN),它们具有与侵袭性胰腺癌相同或相似的基因改变。目前对胰腺癌癌前病变的认识可以通过从非侵袭性MCN、IPMN和PanIN向侵袭性癌的进展途径来说明。MCN由卵巢型间质和具有不同程度异型性的上皮内衬组成,偶尔与侵袭性腺癌相关。非侵袭性IPMN的上皮表现出多种不同的分化方向,包括胃型、肠型、胰胆管(PB)型和嗜酸细胞型。IPMN也可具有不同程度的结构和细胞学异型性。局限于分支导管的IPMN大多为胃型,累及主胰管的IPMN常为肠型,而PB型和嗜酸细胞型则少见。小(<1 cm)的胃型IPMN在形态学上并不总是与低级别PanIN区分开来。黏液表达谱表明肠型IPMN进展为黏液性非囊性(胶样)癌,而PB型IPMN进展为导管腺癌。一个已被充分描述的模式是,PanIN病变通过逐步的基因改变进展为导管腺癌。PanIN病变以及胰腺腺癌中Hedgehog和Notch信号通路的激活表明,在胰腺癌发生过程中发育途径可能失调。需要进一步研究来阐明从癌前病变到胰腺侵袭性癌的途径。